ATE86497T1 - USE OF IGF-I IN THE MANUFACTURE OF A PREPARATION FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF HYPERINSULINEMIA IN DIABETICS TREATED WITH INSULIN. - Google Patents

USE OF IGF-I IN THE MANUFACTURE OF A PREPARATION FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF HYPERINSULINEMIA IN DIABETICS TREATED WITH INSULIN.

Info

Publication number
ATE86497T1
ATE86497T1 AT89810074T AT89810074T ATE86497T1 AT E86497 T1 ATE86497 T1 AT E86497T1 AT 89810074 T AT89810074 T AT 89810074T AT 89810074 T AT89810074 T AT 89810074T AT E86497 T1 ATE86497 T1 AT E86497T1
Authority
AT
Austria
Prior art keywords
hyperinsulinemia
igf
insulin
prevention
manufacture
Prior art date
Application number
AT89810074T
Other languages
German (de)
Inventor
Ernst Rudolf Prof Dr Froesch
Hans-Peter Dr Guler
Christoph Dr Schmid
Juergen Prof Dr Zapf
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority claimed from EP89810074A external-priority patent/EP0331630B1/en
Application granted granted Critical
Publication of ATE86497T1 publication Critical patent/ATE86497T1/en

Links

AT89810074T 1988-02-05 1989-01-26 USE OF IGF-I IN THE MANUFACTURE OF A PREPARATION FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF HYPERINSULINEMIA IN DIABETICS TREATED WITH INSULIN. ATE86497T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88810072 1988-02-05
EP89810074A EP0331630B1 (en) 1988-02-05 1989-01-26 Use of igf-i for the manufacture of a preparation for treating and preventing secondary effects of hyperinsulinemia in diabetics treated with insulin

Publications (1)

Publication Number Publication Date
ATE86497T1 true ATE86497T1 (en) 1993-03-15

Family

ID=26118579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89810074T ATE86497T1 (en) 1988-02-05 1989-01-26 USE OF IGF-I IN THE MANUFACTURE OF A PREPARATION FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF HYPERINSULINEMIA IN DIABETICS TREATED WITH INSULIN.

Country Status (1)

Country Link
AT (1) ATE86497T1 (en)

Similar Documents

Publication Publication Date Title
DE68905205D1 (en) USE OF IGF-I FOR PRODUCING A PREPARATION FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF HYPERINSULINEMIA IN DIABETICIANS TREATED WITH INSULIN.
DE122007000002I2 (en) A pharmaceutical preparation for use in the treatment of diabetes.
ATE127342T1 (en) USE OF MODAFINIL FOR PRODUCING AN ANTISCHEMIC DRUG.
ATE29729T1 (en) NEW INSULIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE, AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF DIABETES MELLITUS.
DE59006880D1 (en) Device for the production of moldings and use thereof for the production of inlays, onlays and crowns in dentistry.
DE69327891T2 (en) Material for removing pathogenic substance and blood filter made with this material
DE122005000002I1 (en) Use of venlafaxine or an aryloxy-propanamine derivative for the manufacture of a medicament for the treatment of incontinence.
HU903206D0 (en) Fungicide preparatives containing oximeters and process for producing the active substances
DE68910175T3 (en) Adsorber module and adsorber apparatus for the treatment of whole blood.
DE68914657D1 (en) DEVICE FOR PRODUCING ICE BALLS AND APPLYING THE SAME PURPOSE TO SURFACE TREATMENT.
DE68924714D1 (en) USE OF ESSENTIAL FATTY ACIDS FOR THE PRODUCTION OF A MEDICINE FOR THE TREATMENT OF ECZEMAS.
DE69635298D1 (en) Use of acetylsalicylic acids for the manufacture of a medicament for the treatment of skin injuries
DE69423577D1 (en) Use of oenothein B in the manufacture of a medicament for the treatment of disorders caused by hyperandrogenicity.
DE3777521D1 (en) COMPOSITE MATERIAL FOR MEDICAL OR PARAMEDIC, PREFERRED ORTHOPEDIC APPLICATION, AND METHOD FOR THE PRODUCTION THEREOF.
DE69328307D1 (en) COMBINATION OF ATOVAQUONE WITH PROGUANIL FOR THE TREATMENT OF PROTOZOE INFECTION
ATE86497T1 (en) USE OF IGF-I IN THE MANUFACTURE OF A PREPARATION FOR THE TREATMENT AND PREVENTION OF SIDE EFFECTS OF HYPERINSULINEMIA IN DIABETICS TREATED WITH INSULIN.
DE69300037T2 (en) Use of bucillamine in the manufacture of a medicament for the treatment of cystinuria.
DE69205535D1 (en) Process for the preparation of phenylbutyronitriles and use in the perfumery of 2,2-dimethyl-4-phenyl-valeriannitrile.
DE3852733T2 (en) Process for the preparation of copolymers in pearl form and their use.
DE68913779D1 (en) D-amidase and process for the preparation of D-alpha-alanine and / or L-alpha-alaninamide.
DE59104754D1 (en) Transparent, thermoplastic polyetheresteramide imide elastomers and their use in the manufacture of medical articles.
DE58901122D1 (en) USE OF TNF AND LT IN THE PRODUCTION OF MEDICINAL PRODUCTS.
DE69311286D1 (en) Use of melatonin in the manufacture of a medicament for the treatment of scleroderma and sarcoidosis
DE68914886T2 (en) Agent for the treatment of Raynaud's disease.
ATE98127T1 (en) USE OF PEROXIDE LIPIDES IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF CIRCULATORY FAILURE BY LOCAL APPLICATION.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time